EnGeneIC Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • 2ndary - Private

EnGeneIC General Information

Description

Developer of a clinical-stage biopharmaceutical company designed to target the delivery of chemotherapeutics and functional nucleic acids in cancer. The company's Cyto-immunotherapy technology utilizes antibody-targeted, bacterial-derived, non-living nano cells to release high concentrations of chemotherapeutic agents, molecularly targeted drugs, and RNA-interference molecules directly into targeted tumor cells, helping patients with cancer treatments that are potent and less toxic, while also offering a potential new means for treating drug-resistant cancers.

Contact Information

Website
www.engeneic.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Level 4, Building 53
  • 11 Julius Avenue, North Ryde
  • Sydney, New South Wales 2113
  • Australia
+61 (02)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Level 4, Building 53
  • 11 Julius Avenue, North Ryde
  • Sydney, New South Wales 2113
  • Australia
+61 (02)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EnGeneIC Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 01-Mar-2026 Completed Clinical Trials - Phase 2
8. Later Stage VC 20-Nov-2021 Cancelled Clinical Trials - Phase 2
7. IPO 22-Nov-2021 Cancelled Clinical Trials - Phase 2
6. Equity Crowdfunding 20-Nov-2021 Completed Clinical Trials - Phase 2
5. Later Stage VC 13-Apr-2017 Completed Clinical Trials - Phase 2
4. Later Stage VC 24-Jul-2015 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series B) 06-Jan-2015 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series A) 30-Apr-2014 $44.6M $45.6M Completed Pre-Clinical Trials
1. Seed Round 27-Jul-2011 $1.02M $1.02M Completed Startup
To view EnGeneIC’s complete valuation and funding history, request access »

EnGeneIC Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class A
To view EnGeneIC’s complete cap table history, request access »

EnGeneIC Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical-stage biopharmaceutical company designed to target the delivery of chemotherapeutics and functio
Drug Discovery
Sydney, Australia
49 As of 2025

Mawson Lakes, Australia
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EnGeneIC Competitors (30)

One of EnGeneIC’s 30 competitors is Carina Biotech, a Venture Capital-Backed company based in Mawson Lakes, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Carina Biotech Venture Capital-Backed Mawson Lakes, Australia
Genentech Formerly VC-backed South San Francisco, CA
Kira Biotech Venture Capital-Backed Toowong, Australia
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
You’re viewing 5 of 30 competitors. Get the full list »

EnGeneIC Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

EnGeneIC FAQs

  • When was EnGeneIC founded?

    EnGeneIC was founded in 2001.

  • Where is EnGeneIC headquartered?

    EnGeneIC is headquartered in Sydney, Australia.

  • What is the size of EnGeneIC?

    EnGeneIC has 49 total employees.

  • What industry is EnGeneIC in?

    EnGeneIC’s primary industry is Drug Discovery.

  • Is EnGeneIC a private or public company?

    EnGeneIC is a Private company.

  • What is EnGeneIC’s current revenue?

    The current revenue for EnGeneIC is .

  • How much funding has EnGeneIC raised over time?

    EnGeneIC has raised $63.7M.

  • Who are EnGeneIC’s competitors?

    Carina Biotech, Genentech, Kira Biotech, Alnylam Pharmaceuticals, and Inovio Pharmaceuticals are some of the 30 competitors of EnGeneIC.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process